Tevogen Bio Holdings Inc.(TVGN)

Biotechnology · Warren, NJ

$6.93+0.33 (+5.00%)

Delayed quote: Oct 6, 2026, 3:49 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:54:16.720Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:54:16.720Z.

Quote observation: 2026-10-06T19:49:31.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 28,857,941
Total debt · period ending 2026-06-30: 3,042,832
Cash · period ending 2026-06-30: 1,082,155
TTM operating EBITDA · period ending 2026-06-30: -20,906,530

FMP input reference: 0d3a12511cd932522e29841d112ac79c3666bd2c66ede85cfa79360bad82955a

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TVGN EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

TVGN Competitors' EV/EBITDA Ratio

TVGN

Tevogen Bio Holdings Inc.

Current

Market Cap

$28.86M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONMD

OneMedNet Corporation

vs TVGN

Market Cap

$28.59M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs TVGN

Market Cap

$29.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs TVGN

Market Cap

$29.74M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QUCY

Quantum Cyber N.V.

vs TVGN

Market Cap

$29.60M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs TVGN

Market Cap

$29.67M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs TVGN

Market Cap

$29.89M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATYR

aTyr Pharma, Inc.

vs TVGN

Market Cap

$27.79M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RMTI

Rockwell Medical, Inc.

vs TVGN

Market Cap

$30.43M

EV/EBITDA Ratio

N/A

TTM Avg

26.23x

3Y Avg

26.23x

5Y Avg

26.23x

MCRB

Seres Therapeutics, Inc.

vs TVGN

Market Cap

$28.03M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Tevogen Bio Holdings Inc. (TVGN)	$28.86M	N/A	N/A	N/A	N/A
OneMedNet Corporation (ONMD)vs ›	$28.59M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$29.32M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$29.74M	N/A	N/A	N/A	N/A
Quantum Cyber N.V. (QUCY)vs ›	$29.60M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$29.67M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$29.89M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$27.79M	N/A	N/A	N/A	N/A
Rockwell Medical, Inc. (RMTI)vs ›	$30.43M	N/A	26.23x	26.23x	26.23x
Seres Therapeutics, Inc. (MCRB)vs ›	$28.03M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics